- Home
- SNGX vs TGHL Comparison
SNGX vs TGHL Comparison
Compare SNGX & TGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- TGHL
- Stock Information
- Founded
- SNGX 1987
- TGHL 2020
- Country
- SNGX United States
- TGHL Singapore
- Employees
- SNGX N/A
- TGHL N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- TGHL EDP Services
- Sector
- SNGX Health Care
- TGHL Technology
- Exchange
- SNGX Nasdaq
- TGHL Nasdaq
- Market Cap
- SNGX 13.8M
- TGHL 15.9M
- IPO Year
- SNGX 1987
- TGHL 2025
- Fundamental
- Price
- SNGX $1.48
- TGHL $0.55
- Analyst Decision
- SNGX Strong Buy
- TGHL
- Analyst Count
- SNGX 1
- TGHL 0
- Target Price
- SNGX $6.00
- TGHL N/A
- AVG Volume (30 Days)
- SNGX 256.3K
- TGHL 58.9K
- Earning Date
- SNGX 11-07-2025
- TGHL 05-01-2026
- Dividend Yield
- SNGX N/A
- TGHL N/A
- EPS Growth
- SNGX N/A
- TGHL N/A
- EPS
- SNGX N/A
- TGHL N/A
- Revenue
- SNGX N/A
- TGHL $173,668.00
- Revenue This Year
- SNGX N/A
- TGHL N/A
- Revenue Next Year
- SNGX N/A
- TGHL N/A
- P/E Ratio
- SNGX N/A
- TGHL N/A
- Revenue Growth
- SNGX N/A
- TGHL 84.40
- 52 Week Low
- SNGX $1.09
- TGHL $0.53
- 52 Week High
- SNGX $6.23
- TGHL $4.25
- Technical
- Relative Strength Index (RSI)
- SNGX 47.15
- TGHL N/A
- Support Level
- SNGX $1.25
- TGHL N/A
- Resistance Level
- SNGX $1.47
- TGHL N/A
- Average True Range (ATR)
- SNGX 0.11
- TGHL 0.00
- MACD
- SNGX 0.02
- TGHL 0.00
- Stochastic Oscillator
- SNGX 65.45
- TGHL 0.00
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About TGHL The GrowHub Limited Class A Ordinary Shares
The Growhub Ltd operates at the intersection of technology and supply chain management in the food industry, focusing on enhancing product traceability and authenticity. With a commitment to innovation and sustainability, It has developed a multi-faceted approach to address industry challenges. its business currently comprises two main divisions, which are the GrowHub Platform and its product trading facilitation offering.